NCT01749046View on ClinicalTrials.gov

Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures

PHASE3CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

December 31, 2013

Conditions
EpilepsySimple Partial SeizuresComplex Partial SeizuresPartial Seizures With Secondary Generalization
Interventions
DRUG

Remegal

Remegal 1500 mg for 12 weeks

Trial Locations (9)

127083

Moscow regional psychiatric hospital, Moscow

150007

Medical unit of disel equipment, Yaroslavl

193167

State psychiatric hospital №6, Saint Petersburg

214019

State Medical Academy, Smolensk

430030

Republican psychiatric dispensary, Saransk

443099

State Medical University, Samara

620036

Sverdlovsk region neuropsychiatric clinic, Yekaterinburg

630091

State Medical University, Novosibirsk

650036

Region psychiatric clinic, Kemerovo

All Listed Sponsors
lead

Valexfarm

INDUSTRY

NCT01749046 - Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures | Biotech Hunter | Biotech Hunter